APOL1: The Balance Imposed by Infection, Selection, and Kidney Disease

被引：28
作者：
Beckerman, Pazit [1 ,2 ,3 ]
Susztak, Katalin [1 ,2 ]
机构：
[1] Univ Penn, Perelman Sch Med, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA
[3] Sheba Med Ctr, Inst Nephrol & Hypertens, Tel Hashomer, Israel
来源：
TRENDS IN MOLECULAR MEDICINE | 2018年 / 24卷 / 08期
关键词：
TRYPANOSOME LYTIC FACTOR; STAGE RENAL-DISEASE; RESISTANCE-ASSOCIATED PROTEIN; LIPID-BINDING PROTEIN; RISK VARIANTS; APOLIPOPROTEIN L1; AFRICAN TRYPANOSOMES; FUNCTION DECLINE; INNATE IMMUNITY; GENE VARIANTS;
D O I：
10.1016/j.molmed.2018.05.008
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Chronic kidney disease (CKD) affects millions of people and constitutes a major health and financial burden worldwide. People of African descent are at an increased risk of developing kidney disease, which is mostly explained by two variants in the Apolipoprotein L1 (APOL1) gene that are found only in people of west African origin. It is hypothesized that these variants were genetically selected due to the protection they afford against African sleeping sickness, caused by the parasite Trypanosoma brucei. Targeting mutant APOL1 could have substantial therapeutic potential for treating kidney disease. In this review, we will describe the intriguing interplay between microbiology, genetics, and kidney disease as revealed in APOL1-associated kidney disease, discuss APOL1-induced cytotoxicity and its therapeutic implications.
引用
收藏
页码：682 / 695
页数：14
相关论文
共 50 条
  • [21] APOL1 toxin, innate immunity, and kidney injury
    Limou, Sophie
    Dummer, Patrick D.
    Nelson, George W.
    Kopp, Jeffrey B.
    Winkler, Cheryl A.
    KIDNEY INTERNATIONAL, 2015, 88 (01) : 28 - 34
  • [22] APOL1 and Cardiovascular Disease A Story in Evolution
    Bajaj, Archna
    Susztak, Katalin
    Damrauer, Scott M.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37 (09) : 1587 - 1589
  • [23] Human apolipoprotein L1 (ApoL1) in cancer and chronic kidney disease
    Hu, Chien-An A.
    Klopfer, Edward I.
    Ray, Patricio E.
    FEBS LETTERS, 2012, 586 (07) : 947 - 955
  • [24] APOL1 Genotype and Glomerular and Tubular Kidney Injury in Women With HIV
    Jotwani, Vasantha
    Shlipak, Michael G.
    Scherzer, Rebecca
    Parekh, Rulan S.
    Kao, W. H. Linda
    Bennett, Michael
    Cohen, Mardge H.
    Nowicki, Marek
    Sharma, Anjali
    Young, Mary
    Tien, Phyllis C.
    Parikh, Chirag R.
    Estrella, Michelle M.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 65 (06) : 889 - 898
  • [25] APOL1 Variants From Parasites to Kidney Function to Cardiovascular Disease
    Reiner, Alex P.
    Susztak, Katalin
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36 (02) : 219 - 220
  • [26] APOL1 variants and kidney disease in people of recent African ancestry
    Genovese, Giulio
    Friedman, David J.
    Pollak, Martin R.
    NATURE REVIEWS NEPHROLOGY, 2013, 9 (04) : 240 - 244
  • [27] Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
    Genovese, Giulio
    Friedman, David J.
    Ross, Michael D.
    Lecordier, Laurence
    Uzureau, Pierrick
    Freedman, Barry I.
    Bowden, Donald W.
    Langefeld, Carl D.
    Oleksyk, Taras K.
    Knob, Andrea L. Uscinski
    Bernhardy, Andrea J.
    Hicks, Pamela J.
    Nelson, George W.
    Vanhollebeke, Benoit
    Winkler, Cheryl A.
    Kopp, Jeffrey B.
    Pays, Etienne
    Pollak, Martin R.
    SCIENCE, 2010, 329 (5993) : 841 - 845
  • [28] APOL1 variants and kidney disease. There is no such thing as a free lunch
    Kronenberg, Florian
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (03) : 775 - 778
  • [29] Small molecule APOL1 inhibitors as a precision medicine approach for APOL1-mediated kidney disease
    Zimmerman, Brandon
    Dakin, Leslie A.
    Fortier, Anne
    Nanou, Evanthia
    Blasio, Angelo
    Mann, James
    Miller, Howard
    Fletcher, Marissa
    Wang, Tiansheng
    Nanthakumar, Suganthini
    Mccarthy, Gizelle
    Matar, Caline
    Matsye, Prachi
    Wang, Guanyu
    Snyder, Phillip
    Daniel, Kevin
    Swamy, Harsha
    Sullivan, Kelly
    Bright, Franklin
    Powers, Audrey
    Gagnon, Kevin J.
    Lu, Fan
    Paula, Steven
    Khare-Pandit, Suvarna
    Henry, Larry
    Hamel, Martine
    Denis, Francois
    Nicolas, Olivier
    Hariparsad, Niresh
    Kumar, Shyamesh
    Proctor, Jennifer
    Senter, Timothy
    Furey, Brinley
    Bunnage, Mark E.
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [30] APOL1 Kidney Risk Alleles: Population Genetics and Disease Associations
    Limou, Sophie
    Nelson, George W.
    Kopp, Jeffrey B.
    Winkler, Cheryl A.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2014, 21 (05) : 426 - 433
12345